Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-15 Purchase |
2025-01-16 6:06 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
15,000 | $2.92 | $43,800 | 51,472 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Tax Withholding |
2025-04-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER |
8,399 | $1.58 | 118,493 (Direct) |
View |
| 2025-03-31 Tax Withholding |
2025-04-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER |
6,044 | $1.58 | 122,593 (Direct) |
View |
| 2025-03-31 Tax Withholding |
2025-04-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
8,828 | $1.58 | 135,501 (Direct) |
View |
| 2025-03-31 Tax Withholding |
2025-04-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
30,498 | $1.58 | 445,563 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-23 4:15 pm |
N/A 2035-01-20 |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER |
230,000 | $0 | 230,000 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-23 4:15 pm |
N/A 2035-01-20 |
VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER |
230,000 | $0 | 230,000 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-23 4:15 pm |
N/A 2035-01-20 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
230,000 | $0 | 230,000 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-23 4:15 pm |
N/A 2035-01-20 |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
730,000 | $0 | 730,000 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-02 5:45 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER |
4,675 | $3.35 | 126,892 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-02 5:45 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER |
4,857 | $3.35 | 128,637 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-02 5:45 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
4,697 | $3.35 | 144,329 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-02 5:45 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
24,536 | $3.35 | 476,061 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | Borowski Christine Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | Basta Steven L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-11-30 Option Award |
2024-12-03 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
3,901 | $2.1 | 500,597 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER |
84 | $1.88 | 131,567 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER |
109 | $1.88 | 133,494 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
685 | $1.88 | 496,696 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
105 | $1.88 | 149,026 (Direct) |
View |
| 2024-07-01 Tax Withholding |
2024-07-03 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER |
92 | $1.92 | 131,651 (Direct) |
View |
| 2024-07-01 Tax Withholding |
2024-07-03 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER |
138 | $1.92 | 133,603 (Direct) |
View |
| 2024-07-01 Tax Withholding |
2024-07-03 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
143 | $1.92 | 149,131 (Direct) |
View |
| 2024-07-01 Tax Withholding |
2024-07-03 4:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
935 | $1.92 | 497,654 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 4:30 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
4,429 | $2.159 | 498,589 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:08 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER |
94 | $3.08 | 131,743 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:06 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER |
157 | $3.08 | 133,741 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:04 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
161 | $3.08 | 149,274 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 5:02 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO |
1,004 | $3.08 | 494,160 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:22 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
62,500 | $0 | 194,337 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-03 5:22 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
93 | $2.28 | 194,337 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:21 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
62,500 | $0 | 196,398 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-03 5:21 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
157 | $2.28 | 196,398 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:20 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
62,500 | $0 | 211,935 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-03 5:20 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
161 | $2.28 | 211,935 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:17 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
225,000 | $0 | 720,164 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-03 5:17 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
1,004 | $2.28 | 720,164 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:14 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:13 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:11 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director |
20,000 | $0 | 20,000 (Direct) |
View |